As you can see, we have three main priorities to work on:

Clinical characterization/common CRF:  Global COVID-19 Clinical Data Platform, COVID-19 observational cohort studies. Encourage member states to submit clinical anonymized data to our Global Platform.  Email EDCARN@who.int for log-in information.   Open.  Weekly reports.

Modify CRF: make module with bare minimum variables, for ease of use in resource limited settings; add pregnancy related components. Deadline one week.

Encourage clinical researchers to conduct observational cohort studies--use ISARIC CCP for biological sampling to understand transmission. Ongoing

Core clinical outcome set for clinical trials:  Delphi process to produce set-be prepared to fill out survey shortly.  Deadline one week.

Interventional studies:High flow oxygen: evaluate extent of aerosol production (IPC)-protocol in development. Deadline two weeks.

Steroids and COVID-19 disease: review REMAP-CAP study protocol (see link below). Systematic review commissioned.  Deadline one week to review trial protocol, to be discussed at next TC.

Develop optimized supportive care protocol. Deadline 3 weeks.

Our working group governance (in development) but includes:

Co chairs: John and Srin will continue.  YaeJean to support back up as needed.

Group members:  agree to participate in group and contribute scientifically. If you do not desire to participate please let me know.  All have signed confidentiality agreements.

New members: Add methodologist to the panel and ensure adequate regional representation. Increase representation from China. 

Weekly TCs to discuss scientific issues, and move forward the agenda.